We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
The Best dot dot is a positive review website that lets individuals celebrate the good things in life and in turn, enables others to benefit from those experiences. The company aims to create a leading platform, with a large, engaged user base and ultimately to maximise shareholder value. The company has a full robust technology infrastructure and platform in place, consisting of a mix of unique in house technology and tried and tested industry-standard platforms. Significant work has already been done to create the IP that will be purchased by the company and the funds raised will be used to build on the work already done and to take the business to the next level. By increasing the user base, the revenue will rapidly increase as the company introduces additional revenue streams.

Pitch Rated

51%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £19,050
Carocell Bio is an early-stage Research and Design (R&D) company aiming to develop nanoparticle-based, novel peptide anti-inflammatories to treat atopic dermatitis/eczema (AD) and other serious inflammatory diseases. It argues that millions of people continue to be affected by debilitating skin ailments, which in turn, escalates the development of new pharmaceutical drugs. The company asserts that the anti-inflammatory therapeutics market will reach US$122.6 billion by 2025 from US$95.9 billion in 2019. The company aims to be a major contender in this market. Carocell Bio has also been awarded an Innovate UK grant of £390,874. The company is seeking £1 million in equity investment over the next 12 months to show that their compounds work in human tissue biopsies of several inflammatory diseases.

Pitch Rated

45%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: Withheld
Themis is a regulatory technology company that helps organisations mitigate the risk and impact of all forms of financial crime such as money laundering, bribery, corruption, cybercrime, theft, slavery/human trafficking, and fraud. The platform is designed to provide insights and intelligence on the latest threats, trends, and criminal techniques whilst helping clients complete due diligence on their clients, staff, and supply chains. Themis works alongside the Themis Charitable Trust to ensure the reduction of financial crime. The company also supports the UN Global Compact taking into account the fundamental responsibilities of business in the areas of human rights, labour, environment, and anti-corruption. Themis will use the investment to grow its business across different verticals.

Pitch Rated

37%

Insufficient Data

rating powered by

CROWD RATING™

days to go: Expired investment: £1,300,000
Screach provides consumer focused venues with the ability to intelligently engage and interact with their customers via installed digital displays (TVs) and mobile phones. The Screen Reach software dynamically changes the screen content to improve its effectiveness in driving more sales by displaying relevant engaging content and promotions. 
days to go: Expired investment: £590,000
AgPlus has created a diagnostic platform for detecting human diseases and delivering laboratory instrument results instantly, whilst keeping in mind the business requirements and unmet requirements. The company works in collaboration with leading diagnostics companies to improve and share products quickly and globally. It aims is to become known as a leader in Point of Care diagnosis.
days to go: Expired investment: £65,004
A car-sharing platform for drivers to receive an extra income by allowing the local community to drive their cars instead of leaving it idle and unused. Hiyacar has a acquired an exclusive insurance product with AXA and already has more than 2,000 cars enrolled, with the majority located in London and surrounding urban areas with the intention of expanding further in the future.
days to go: Expired investment: £1,431,885
International Ambulances (IA) aims to save lives and to provide better outcomes for patients, paramedics and hospitals. The company is building a revolutionary ambulance the 'ACESO' that will be the first ever purpose built global ambulance. ACESO will address known challenges of accident & emergency departments and promote the NHS 'See and Treat' strategy. Of the ambulance fleet size of 14,000, International Ambulances (IA) has identified about 1,200 A&E Ambulances of which the opportunity for ACESO is 500 per year. 
days to go: Expired investment: £251,600
Tethered Drones Systems Limited (TDS) builds and develops autonomous tethered drones for use in surveillance and communications scenarios. Its product, Tethered UAV, exhibits a flight duration of 24 hours or more with secure communication via a tether. The platform can carry a range of payloads to meet client needs. The company asserts that the product has multiple uses for broadcasters such as telecasting outdoor sporting events. The UAV's blue light services, including search and rescue, holds prominence in high-risk maintenance inspections for oil and gas platforms and wind farms – both on and offshore. The company will use the investment to grow its business across different verticals.
days to go: Expired investment: £73,125
Ablatus Therapeutics is a MedTech company developing a one-of-a-kind tissue ablation platform known as Bimodal Electric Tissue Ablation (BETA). This technology has been designed to overcome the limitations of existing products by offering ablation solutions in oncology (tumours) as well as non-oncology targets. With the proceeds, the company will finish the final elements of engineering of the generator and probe. It will also deliver formal safety test data that is a prerequisite for subsequent clinical trials.
days to go: Expired investment: Withheld
Adapttech aim to reduce the number of sessions needed to adjust a prosthetic to it’s owner, making prosthetics more comfortable at a much faster rate. Their technology uses a laser scanner combined wearale sensors to determine where the socket needs adjustments.
days to go: Expired investment: £1,225,000
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph